- The Indian Council Medical Research is closer to having the world's first male contraceptive as it completes its clinical trial
- When the drug is finally approved, it will be effective for 13 years in a male carrier before it loses its capacity
- It is said that men in India would prefer the injectable male contraceptive to surgical vasectomy that is presently obtainable
PAY ATTENTION: Click “See First” under the “Following” tab to see Briefly.co.za News on your News Feed!
The Indian Council of Medical Research (ICMR) has successfully completed clinical trials of the world’s first injectable male contraceptive, and it has been sent to the Drug Controller General of India (DCGI) for approval.
According to Hindustantimes, if the birth control pill is finally approved, when injected it would be effective for 13 years in the carrier.
The same media also reports that injection is an alternative to the only form of male birth control which is surgical vasectomy.
It should be noted that the ICMR is the final body in India that oversees biomedical research and gets its funding from the government at the union ministry of health.
HT reports that 53.5% of Indian couples use birth spacing methods, permanent sterilization is the most popular.
READ ALSO: Man nearly flies off truck after failing to hold onto metal sheets
Doctors in the country are of the opinion that injectable male contraceptives will be most demanded-for than surgical vasectomy as Dr Anup Kumar said men will opt for it.
“Non-surgical procedures are always preferred over surgical procedures because they will be safer and less invasive. More men are likely to opt for it,” he said.
There is, however, a challenge in the face of the drug once it gets approval; the government will need to publicise it for it to gain wide acceptability.
AR Nanda, a former family welfare secretary is one of such people with the above opinion, adding that incentives for people who go for the option are also necessary.
“Two things are needed from the government for it to work; one is to make use of the trial subjects for awareness generation among masses about the product, and second is to offer higher incentives for people opting for male contraceptives,” Nanda said.
Enjoyed reading our story? Download BRIEFLY's news app on Google Play now and stay up-to-date with major South African news!